Free Trial

Nutex Health (NASDAQ:NUTX) Stock Price Down 7.3% - Time to Sell?

Nutex Health logo with Medical background

Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s stock price dropped 7.3% during mid-day trading on Tuesday . The company traded as low as $105.00 and last traded at $103.03. Approximately 142,275 shares traded hands during trading, an increase of 12% from the average daily volume of 127,585 shares. The stock had previously closed at $111.19.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on NUTX. Maxim Group increased their target price on shares of Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a research report on Tuesday, May 20th. Benchmark increased their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th. Finally, Wall Street Zen lowered shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 22nd.

View Our Latest Stock Analysis on NUTX

Nutex Health Trading Down 0.8%

The firm has a fifty day moving average of $128.90 and a 200 day moving average of $94.99. The firm has a market capitalization of $527.84 million, a PE ratio of 7.99 and a beta of -0.04. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.26 and a current ratio of 2.27.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating the consensus estimate of ($0.15) by $2.71. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%. The business had revenue of $211.79 million during the quarter, compared to the consensus estimate of $81.09 million.

Institutional Investors Weigh In On Nutex Health

Several hedge funds and other institutional investors have recently bought and sold shares of NUTX. KLP Kapitalforvaltning AS bought a new stake in shares of Nutex Health during the second quarter valued at approximately $112,000. Bank of America Corp DE increased its stake in Nutex Health by 6,590.3% during the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after buying an additional 2,043 shares during the period. Austin Asset Management Co Inc bought a new stake in shares of Nutex Health during the 2nd quarter worth about $315,000. Clear Creek Financial Management LLC acquired a new stake in shares of Nutex Health in the 2nd quarter worth approximately $397,000. Finally, Northern Trust Corp bought a new position in shares of Nutex Health in the fourth quarter valued at approximately $200,000. 5.32% of the stock is currently owned by hedge funds and other institutional investors.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Further Reading

Should You Invest $1,000 in Nutex Health Right Now?

Before you consider Nutex Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.

While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

ACT FAST! Congress is Dumping these 3 Stocks
3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines